Yassmine Akkari, PhD, FACMG, is the scientific director of cytogenetics and molecular pathology at Legacy Health in Portland, Oregon. As part of her responsibilities, she and her team of cytogenetic and molecular technologists oversee clinical genetic testing including conventional cytogenetics, chromosomal microarray analysis, and FISH on all specimen types, as well as somatic next-generation sequencing and infectious disease. Yassmine is currently serving as the president of the Cancer Genomics Consortium, the vice chair of the CAP/ACMG Cytogenetics resource Committee, vice chair of AMP’s Training and Education Committee, and is a member of the Children’s Oncology Group Cytogenetics Committee. She has published more than 30 peer-reviewed articles and two book chapters.